Fact-checked by Grok 2 weeks ago

Fever

A fever, also known as pyrexia, is defined as a temporary elevation in an individual's core body temperature above the normal hypothalamic set-point, typically exceeding 100.4°F (38°C) when measured rectally. This physiological response is a regulated increase orchestrated by the body's thermoregulatory center in the , triggered by pyrogens such as cytokines (e.g., interleukin-1 and interleukin-6) released during or . While often a beneficial component of the immune system's defense against pathogens, fever is not a itself but a symptom indicating an underlying condition, most commonly an . The mechanism of fever involves the raising the body's temperature set-point to enhance immune function, such as by increasing metabolic rate (approximately 10–12.5% per 1°C rise) and improving the activity of while stressing invading microorganisms. Normal body temperature is traditionally considered to average 98.6°F (37°C), though recent studies suggest a lower average of approximately 97.9°F (36.6°C); it can vary by up to 0.5°C diurnally or by measurement site (e.g., rectal readings are typically about 0.5°C (0.9°F) higher than oral). Fevers are classified by severity: low-grade (99.1–100.4°F or 37.3–38.0°C), moderate (100.6–102.2°F or 38.1–39.0°C), high-grade (102.4–105.8°F or 39.1–41°C), and hyperpyrexia (>105.8°F or 41°C), the last of which risks organ damage if prolonged. In vulnerable populations like infants under 3 months, the elderly, or immunocompromised individuals, fever may present atypically or even as . The primary causes of fever are infectious agents, accounting for about 74% of cases in hospitalized patients, including bacterial (e.g., , urinary tract infections) and viral pathogens (e.g., , ). Non-infectious etiologies include autoimmune disorders (e.g., ), malignancies, drug reactions, inflammatory conditions, and even vaccinations like DTaP or shots. Accompanying symptoms often involve chills, sweating, , muscle aches, , loss of appetite, and , though these vary by cause and individual. Diagnosis typically relies on history, , and , with further tests (e.g., blood cultures, ) pursued if the fever persists beyond 3 days or in high-risk cases like infants under 2 months. Management focuses on addressing the underlying cause rather than the fever itself, as mild fevers (<102°F or 38.9°C) generally aid recovery and do not require intervention unless causing discomfort. Over-the-counter antipyretics such as acetaminophen or ibuprofen can reduce temperature and alleviate symptoms, but aspirin is avoided in children due to the risk of . Supportive measures include hydration, rest, light clothing, and a cool environment; immediate medical attention is warranted for temperatures ≥103°F (39.4°C) in adults, seizures, confusion, or fever in neonates. While (lasting >3 weeks without diagnosis) may necessitate specialist evaluation, most fevers resolve spontaneously within a few days.

Introduction and Basics

Definition

Fever, also known as pyrexia, is defined as the elevation of an individual's core body temperature above a set-point regulated by the body's thermoregulatory center in the . This elevation typically exceeds 38°C (100.4°F) orally or rectally, though precise thresholds can range from 37.5°C to 38.3°C (99.5°F to 100.9°F) depending on clinical context and measurement method. The term "fever" derives from the Latin febris, meaning heat or a passionate state associated with burning or . In contrast to normothermia, where core body maintains within a normal range influenced by factors such as age, time of day, and measurement site, fever represents a pathological deviation driven by internal regulatory changes. Normal varies diurnally, lowest in the early morning and peaking in the late afternoon by up to 0.5°C (0.9°F), and differs by age—typically lower in older adults—and site: normal oral temperatures typically range from 36.1°C to 37.2°C (97°F to 99°F), rectal are 0.3–0.5°C higher, axillary 0.5–1.0°C lower, and tympanic approximates oral but with potential variability. Physiologically, fever is a regulated process involving an upward adjustment of the hypothalamic set point, distinguishing it from unregulated conditions like where body temperature rises due to environmental overload or metabolic excess without central modulation.

Normal Body Temperature

The normal human core body temperature typically ranges from 36.1°C to 37.2°C (97°F to 99°F), with an average of 37°C (98.6°F). This value represents the internal temperature maintained by the body's thermoregulatory mechanisms in healthy individuals under standard conditions. Body temperature exhibits a diurnal variation, influenced by the , with the lowest values occurring in the early morning (around 4–6 a.m.) and the highest in the late afternoon (around 4–6 p.m.), typically fluctuating by 0.25–0.5°C throughout the day. sites yield different norms due to anatomical and physiological differences: rectal temperature is generally 0.27–0.38°C higher than oral, providing a closer to temperature, while axillary (armpit) readings are about 0.55°C lower than oral. For instance, average values from systematic reviews indicate rectal at approximately 37.04°C, oral at 36.8°C, and axillary at around 36.3°C. Several factors influence baseline body temperature. Infants and young children often have slightly higher averages (up to 37.5°C), while older adults may trend lower; sex differences show women averaging about 0.2–0.4°C higher than men, particularly during the of the . , such as exercise, can elevate temperature by 1–2°C temporarily due to increased metabolic production, and environmental factors like ambient can raise it further, though the body compensates through sweating and . Common methods for measuring body temperature include digital thermometers (for oral, rectal, or axillary use), tympanic thermometers (ear-based), and non-contact forehead or temporal artery thermometers. Digital thermometers are highly accurate (±0.1°C) when properly placed and are preferred for their reliability and ease of use compared to phased-out models, which had similar precision but posed safety risks. tympanic devices offer quick readings but can be less accurate (±0.2–0.5°C) if obstructs the canal or the probe is not positioned correctly, while forehead models may overestimate or underestimate by up to 0.5°C in varying ambient conditions or with user movement. Common errors across methods include recent ingestion of hot/cold fluids affecting oral readings, shallow insertion in rectal measurements leading to underestimation, or environmental interference (e.g., drafts) skewing results.

Clinical Presentation

Symptoms

Fever typically manifests through a sequence of subjective and objective signs reflecting the body's thermoregulatory adjustments. In the initial phase, individuals often experience or rigors, characterized by shivering and involuntary muscle contractions as the body generates heat to reach the elevated hypothalamic set point. Once the plateau temperature is attained, sensations of warmth and flushed skin predominate, accompanied by that increases by approximately 10 beats per minute for each 1°C rise in core temperature. As the fever resolves during defervescence, profuse sweating occurs to facilitate heat loss and return to baseline temperature. Associated symptoms frequently accompany these core signs, enhancing the overall discomfort. and are among the most prevalent, reported in over 50% and approximately 47% of febrile episodes, respectively, often leading to generalized . , myalgias (muscle aches), and anorexia (loss of appetite) are also common, affecting roughly 45-47% of cases, while may contribute to restlessness. Presentations vary by age group, influencing recognition and management. In infants, fever often appears as , poor feeding, and rather than pronounced or sweating, potentially masking the condition. Adults typically report more classic symptoms like and muscle aches, whereas the elderly exhibit a blunted response, with attenuated fever magnitude and fewer overt signs, increasing the risk of underdetection. Prolonged fever exacerbates these effects, promoting through heightened insensible fluid losses and diminished oral intake, which in severe instances may induce or altered mental status.

Complications

Fever, while often a beneficial , can lead to short-term complications, particularly in children. One of the most common is febrile seizures, which occur in 2–5% of children aged 6 months to 5 years during febrile illnesses, typically those caused by viral infections. These seizures are generally benign, with most children experiencing a full and no long-term neurological sequelae, though they warrant prompt medical evaluation to rule out underlying serious infections. Another short-term risk is , resulting from increased insensible fluid losses through the skin and , exacerbated by and reduced oral intake during illness; this is especially pronounced in infants and young children, where fever can accelerate evaporative losses by up to 10–15% per degree rise above normal. In extreme cases of sustained hyperpyrexia, defined as core body exceeding 41°C, fever can cause severe long-term effects including neuronal damage from blood-brain barrier disruption and , multi-organ failure due to and hypoperfusion, and from muscle breakdown triggered by hypermetabolic states. These complications arise when the body's thermoregulatory mechanisms fail, leading to cellular injury and potential irreversible if not rapidly corrected. Certain populations face heightened risks from fever. Neonates are particularly vulnerable to , as their immature immune systems and nonspecific fever responses can mask rapidly progressing bacterial infections, increasing mortality if untreated. In immunocompromised individuals, such as those with or undergoing , fever often signals disseminated infections that can worsen due to impaired clearance, leading to higher rates of bacteremia and . Elderly patients experience added cardiovascular strain from fever-induced and increased myocardial oxygen demand, which can precipitate arrhythmias or exacerbate underlying heart disease in those over 70 years. Rare but severe outcomes include overlap with in cases of uncontrolled hyperpyrexia, where environmental factors compound endogenous fever, resulting in mortality rates of 10–50% depending on the timeliness of cooling interventions and comorbidities. Prompt therapy and supportive care can mitigate these risks across all groups.

Pathophysiology

Hypothalamic Regulation

The serves as the central thermoregulatory center of the body, with the , particularly the ventral medial preoptic (VMPO) region, acting as the primary that maintains core temperature . This area integrates afferent signals from peripheral thermoreceptors in and central sensors in the viscera, , and itself, as well as humoral inputs from the bloodstream via circumventricular organs like the organum vasculosum of the (OVLT), which lacks a blood-brain barrier. These inputs allow the to continuously monitor and compare actual body temperature against a defended set point, typically around 37°C in humans. During fever, the hypothalamic set point is elevated through (PGE2)-mediated alterations in the thermosensitive neurons of the . Exogenous or endogenous pyrogens induce the expression of (COX-2) in endothelial cells of the OVLT, leading to PGE2 synthesis, which binds to EP3 receptors on VMPO neurons. This binding shifts the thermal sensitivity of these neurons, raising the set point to a higher (often 38–40°C), prompting the to generate and conserve heat until the new equilibrium is reached. To achieve the elevated set point, the activates specific thermoeffector pathways. of cutaneous vessels reduces loss to the by minimizing flow to , while behavioral responses like seeking warmth may also be elicited. For production, thermogenesis involves rhythmic contractions of skeletal muscles coordinated via descending pathways from the to the , generating metabolic . In infants, non- thermogenesis predominates, occurring in through uncoupling protein-1 (UCP-1)-mediated proton leak in mitochondria, which is sympathetically stimulated by the . Fever resolution involves loops that restore the set point to normal once the underlying stimulus diminishes. As circulating pyrogens decrease, PGE2 levels fall, allowing EP3 receptor activity to wane and thermosensitive neurons to regain their baseline sensitivity. Additionally, warmth-sensitive neurons in the , such as those expressing prostaglandin D synthase (Ptgds), detect the elevated core temperature and release (PGD2), which acts on DP1 receptors to suppress heat-generating effectors and promote cooling mechanisms like and sweating. This circuit ensures precise control, preventing excessive and facilitating a return to euthermia.

Pyrogens

Pyrogens are substances that trigger the febrile response by acting on the body's thermoregulatory system. They are broadly classified into endogenous pyrogens, which are produced internally by the host, and exogenous pyrogens, which originate from external sources such as microorganisms. Endogenous pyrogens primarily consist of proinflammatory cytokines released by immune cells, including monocytes, macrophages, and endothelial cells, in response to , , or inflammatory stimuli. Key examples include interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), which are synthesized and secreted during the acute-phase response to elevate body temperature. These cytokines act as mediators that signal the to initiate fever. Exogenous pyrogens are microbial components that directly or indirectly provoke the release of endogenous pyrogens. Prominent among them are (LPS), also known as endotoxin, derived from the outer membrane of , and lipoteichoic acid from the cell walls of . These pathogen-associated molecular patterns bind to toll-like receptors on immune cells, triggering production and subsequent fever induction. The mechanism by which pyrogens induce fever involves their interaction with the blood-brain barrier (BBB) or peripheral sites to promote the synthesis of prostaglandin E2 (PGE2). Circulating pyrogens, such as cytokines, can cross the BBB at circumventricular organs or induce PGE2 production in endothelial cells via activation of cyclooxygenase (COX) enzymes, particularly COX-2, leading to elevated hypothalamic set-point temperature. Exogenous pyrogens similarly stimulate this pathway indirectly through cytokine release. Beyond infectious causes, non-infectious conditions can also elicit fever through the release of endogenous pyrogens. Tissue injury from or prompts macrophage activation and secretion, while malignancies, such as lymphomas or solid tumors, produce pyrogenic s either directly from tumor cells or via associated . Autoimmune diseases, including and systemic lupus erythematosus, involve dysregulated immune responses that elevate IL-1, IL-6, and TNF-α levels, contributing to persistent fever.

Neural Mechanisms

The neural mechanisms of fever involve integrated afferent signaling that detects peripheral pyrogens, central processing via (PGE2), and efferent outputs that elevate body temperature to match the new hypothalamic set point. Peripheral pyrogens, such as cytokines, initiate the cascade by activating sensory pathways that convey inflammatory signals to the brain. Afferent pathways primarily include the and circumventricular organs, which detect circulating pyrogens and transmit signals to the of the . The serves as a rapid neural route, where cytokines like IL-1β activate vagal afferent fibers innervating peripheral sites of , relaying pyrogenic messages directly to the and onward to thermoregulatory centers. Circumventricular organs, particularly the organum vasculosum of the lamina terminalis (OVLT), lack a complete blood-brain barrier and sense blood-borne cytokines, projecting neurons to the median preoptic nucleus to initiate fever signaling. Within the , PGE2, synthesized by endothelial cells in the via and microsomal PGE synthase-1, acts as the key mediator by binding to EP3 receptors on warm-sensitive neurons in the , thereby raising the thermoregulatory set point and triggering conservation and production. This binding disinhibits downstream neurons, integrating afferent inputs to coordinate the febrile response. Efferent outputs from the drive through sympathetic and pathways. Sympathetic activation occurs via projections to the dorsomedial and rostral medullary raphe, stimulating , piloerection, and non-shivering in to reduce heat loss and increase production. motor pathways, also originating from the dorsomedial , engage shivering by exciting spinal motor neurons innervating skeletal muscles, particularly during pronounced fever. Fever resolution involves anti-pyretic neural signals that dampen the inflammatory cascade, such as interleukin-10 (IL-10), which suppresses pro-inflammatory production and thereby reduces PGE2 and EP3 receptor activation. This feedback mechanism restores the thermoregulatory set point once the pyrogenic stimulus subsides.

is characterized by an unregulated elevation in core body temperature resulting from excessive heat production or impaired heat dissipation, without any alteration in the hypothalamic set point, in contrast to the regulated rise seen in fever. This condition typically occurs when environmental factors, physical exertion, or pharmacological influences overwhelm the body's thermoregulatory mechanisms, leading to temperatures often exceeding 40°C. Common causes of hyperthermia include heatstroke, which is divided into classic (non-exertional) and exertional forms. Classic heatstroke arises from prolonged exposure to high ambient temperatures, particularly in vulnerable populations such as the elderly or those with chronic illnesses, where impaired sweating and fail to dissipate heat effectively. Exertional heatstroke, on the other hand, stems from intense in hot environments, causing rapid internal heat generation that surpasses cooling capacity, often affecting young, healthy individuals like athletes. Other notable causes are , a triggered by certain anesthetics (e.g., or succinylcholine) that provoke uncontrolled contractions and heat release, and , a rare but life-threatening reaction to antipsychotic medications like , involving blockade that disrupts and leads to muscle rigidity and hyperthermia. Pathophysiologically, induces direct cellular damage through protein denaturation, membrane instability, and disruption of enzymatic functions, culminating in widespread , , and multi-organ dysfunction, unlike the adaptive, immune-enhancing response of fever. At temperatures above 40°C, this can trigger , abnormalities, and endothelial injury, exacerbating systemic collapse. Clinically, differs from fever by the absence of or rigors, as there is no hypothalamic-mediated drive to elevate temperature; instead, it presents with rapid onset of symptoms like , seizures, and hot, dry due to anhidrosis in severe cases. Mortality is notably higher, reaching up to 70% in untreated severe heatstroke, owing to the unchecked progression to irreversible organ failure.

Infectious vs Non-Infectious Causes

Fever in adults is most commonly attributed to infectious etiologies, which represent the leading cause across acute and community settings. Non-infectious causes, while less frequent overall, become more prominent in cases of prolonged or recurrent fever. Infectious causes are diverse and include bacterial, viral, parasitic, and fungal pathogens. Bacterial infections frequently involve sites such as the (e.g., ) or (e.g., urinary tract infections), while viral causes commonly feature or other respiratory viruses. Parasitic infections like are notable in endemic regions, and fungal infections arise particularly in immunocompromised hosts. These pathogens trigger fever through the release of pyrogens that elevate the hypothalamic set point. Non-infectious causes encompass autoimmune disorders, malignancies, drug reactions, and factitious fever. Autoimmune conditions such as or can manifest with persistent low-grade fever due to inflammatory cytokines. Malignancies, including or , often present with fever as a . Drug-induced fever, commonly associated with antibiotics like beta-lactams, results from reactions and accounts for up to 3% of admissions for fever. Factitious fever involves intentional self-induction, typically through manipulation of thermometers or injection of contaminants. Geographic factors influence the prevalence of infectious causes, with tropical regions showing higher rates of vector-borne diseases like and due to environmental suitability for vectors. In contrast, temperate climates more commonly feature bacterial infections such as or . A subset of fevers defies initial classification, termed (FUO), defined by a temperature exceeding 38.3°C on multiple occasions, lasting more than three weeks, and remaining undiagnosed after at least one week of investigation. In FUO among adults, infectious etiologies comprise 20% to 40% of diagnosed cases, noninfectious inflammatory diseases 10% to 30%, malignancies 20% to 30%, and miscellaneous causes 10% to 20%, with up to 50% resolving without a definitive diagnosis.

Diagnostic Approach

Clinical Evaluation

The clinical evaluation of fever commences with a detailed and to ascertain the underlying cause, gauge severity, and guide further management. This bedside assessment is fundamental, as it often reveals localizing clues to or other etiologies without immediate recourse to ancillary tests. Normal body averages 37°C (98.6°F) but varies by and time of day, with fever defined as a rectal temperature ≥38°C in most contexts. History taking focuses on the fever's onset, which may be sudden in bacterial infections or gradual in ones, alongside its duration and pattern—such as intermittent spikes, sustained elevation, or relapsing cycles that can suggest specific conditions like . Associated symptoms, including , sweats, , , , or , provide critical context for . Recent travel history, animal or environmental exposures, occupational risks, and contact with ill individuals are probed to identify infectious sources, while a review of medications (e.g., for drug fever) and status helps exclude vaccine-related reactions or prophylaxis failures. The prioritizes , with accurate temperature measurement (preferably rectal or tympanic) confirming fever, alongside pulse rate—which may show proportional to temperature rise or relative in certain s—and to detect signaling . A systematic head-to-toe survey seeks focal signs of , such as (e.g., petechial in meningococcemia), cervical or generalized , pharyngeal , abdominal tenderness indicating , or joint swelling in . Skin turgor and mucous membranes are assessed for , a common complication. Red flags warranting urgent attention include fever exceeding 40°C (hyperpyrexia), which risks organ damage; altered mental status such as confusion or lethargy, indicating possible or systemic involvement; and , a hallmark of requiring immediate evaluation. These findings prompt expedited intervention to avert complications. Approaches must be tailored by age. In neonates and young infants (under 60 days), any fever ≥38°C triggers a high index of suspicion for , necessitating meticulous assessment of feeding, activity, and subtle signs like or poor , often leading to full workup. For older children and adults, evaluation emphasizes nuanced history elements; adults, in particular, require detailed travel and exposure queries to uncover exotic pathogens like dengue or typhoid.

Laboratory and Imaging

Laboratory evaluation of fever begins with basic tests to identify common infectious or inflammatory causes. A (CBC) with differential is routinely performed, where , often with a predominance of neutrophils, suggests bacterial . (CRP) and (ESR) serve as non-specific markers of inflammation, with elevated levels indicating ongoing systemic response, though they lack specificity for etiology. Blood cultures, ideally obtained from multiple sites before administration, are essential for detecting bacteremia, with three sets recommended to improve yield. with and culture helps rule out urinary tract infections, a frequent source of fever. Advanced laboratory tests are selected based on clinical suspicion to target specific pathogens. (PCR) assays detect viral nucleic acids in respiratory or samples, aiding diagnosis of viral etiologies like or in cases without an apparent source. Serologic testing for antibodies against agents such as or Epstein-Barr virus (EBV) is useful in prolonged or atypical fevers, where positive results confirm prior exposure or acute infection. Imaging modalities complement laboratory findings by visualizing structural abnormalities. Chest X-ray (CXR) is a first-line test for suspected , particularly in febrile patients with respiratory symptoms, offering high sensitivity for infiltrates. (CT) scans of the chest, , or detect occult abscesses or other focal infections not apparent on plain films. In (FUO), defined as fever exceeding 38.3°C for at least three weeks with negative initial evaluation, a stepwise diagnostic approach is employed. Initial non-invasive tests include , CRP, ESR, blood cultures, , CXR, and CT; if inconclusive, antinuclear antibody (ANA) testing screens for autoimmune disorders like systemic . Fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) is increasingly used early in the workup for its ability to identify occult malignancies, infections, or inflammatory foci with high sensitivity. These tests have inherent limitations that must be considered. Blood cultures and can yield false negatives in early due to low bacterial or loads before systemic dissemination. In low-risk cases without suggestive history or exam findings, extensive testing may lack cost-effectiveness, potentially leading to unnecessary expenses without altering management.

Fever Patterns and Types

Fever Curves

Fever curves represent the graphical depiction of body fluctuations over time during a febrile episode, providing insights into the underlying physiological dynamics. These patterns arise from periodic shifts in the hypothalamic set point, which dictate the body's thermoregulatory response to pyrogenic stimuli. To construct a fever curve, serial measurements are typically taken every 4 to 6 hours over 24 to 72 hours, using consistent methods such as oral or for accuracy, allowing clinicians to identify characteristic trends rather than isolated readings. The primary types of fever curves include continuous, intermittent, and remittent patterns, each distinguished by the degree and timing of temperature variations. In a continuous or sustained fever, the temperature remains elevated above 38°C with minimal daily fluctuation (less than 0.3°C to 0.5°C), as seen in conditions like or . An intermittent fever features spikes above 38°C that return to normal (≤37.2°C) at least once daily, often associated with or , and may accompany rigors or sweats. In contrast, a remittent fever shows wide diurnal swings (0.3°C to 1.4°C or more) while persistently staying elevated, commonly observed in viral infections or . Certain variants, such as fever—a subtype of intermittent or remittent with exaggerated swings exceeding 1.4°C—indicate more severe processes, including bacterial septicemia, deep-seated , or . These patterns hold clinical utility in narrowing considerations: for instance, intermittent curves may suggest an or , while hectic fluctuations point toward or , and a diurnal —where peaks in the evening—is typical in , sometimes with reversal of the normal pattern in disseminated cases. However, fever curves alone are not diagnostic and must integrate with other clinical findings. Advancements in monitoring have introduced wearable devices, such as patch-based or wrist-worn sensors, enabling real-time tracking of temperature curves in ambulatory settings for early detection of febrile episodes without frequent visits. These tools, validated for continuous physiological , facilitate remote in outpatient care, particularly for chronic or at-risk patients.

Hyperpyrexia

Hyperpyrexia is defined as a body temperature exceeding 41°C (105.8°F), representing an extreme elevation beyond the normal hypothalamic thermoregulatory set point and distinguishing it from standard fevers. This condition often arises from overwhelming infections, such as bacterial sepsis, where systemic inflammatory responses disrupt thermoregulation, or central nervous system disorders like encephalitis, which directly impair hypothalamic function. Drug reactions, including salicylate toxicity, can also induce hyperpyrexia by uncoupling oxidative phosphorylation and interfering with heat dissipation mechanisms. Hyperpyrexia accelerates complications, including (DIC) due to endothelial damage and widespread clotting activation, as well as from changes and neuronal stress. These risks necessitate urgent , such as rapid cooling and addressing the underlying cause, to prevent multi-organ failure. The for hyperpyrexia is grave in severe cases, particularly those linked to or CNS involvement, far exceeding outcomes for typical fevers due to the rapid progression of tissue injury.

Biological Role

Immune Enhancement

Fever plays an adaptive role in enhancing immune defenses by optimizing various cellular and molecular processes at elevated core temperatures, typically in the range of 38–40°C. One key mechanism involves accelerated migration to sites of , where febrile temperatures upregulate such as CXCL8 (IL-8) via heat shock factor 1 (HSF1), promoting extravasation, respiratory burst, and bacteriolytic activity in the lungs. Additionally, fever-range boosts T-cell proliferation and effector differentiation by enhancing L-selectin shedding and ICAM-1 expression on high endothelial venules, facilitating greater T-cell trafficking and IL-6 trans-signaling across vertebrate species. production is also amplified at these temperatures, with dendritic cells exhibiting increased interferon-α (IFN-α) secretion in response to viral stimuli, thereby strengthening antiviral adaptive immunity. Beyond direct immune cell modulation, fever inhibits proliferation through thermal disruption of microbial processes. For , elevated temperatures denature toxins and enhance efficacy, with studies demonstrating progressive activity from 35°C to 41.5°C. In viral infections, fever slows replication by altering and endosomal , impeding virion entry; for instance, , which replicates optimally at 33°C in the cooler nasal passages, experiences reduced and at 38–40°C. Supporting evidence from animal models underscores these benefits, showing that mild fever confers higher survival rates during infection. In lizards infected with , maintaining body temperatures at 40–42°C post-infection significantly improved survival compared to 34–36°C, highlighting fever's protective role without metabolic overload. Human studies further suggest that suppressing fever with antipyretics can prolong illness in certain infections; for example, in volunteers experimentally infected with rhinovirus, aspirin, acetaminophen, or ibuprofen reduced antibody responses, increased nasal symptoms, and trended toward extended . The evolutionary conservation of fever across vertebrates, spanning over 600 million years, indicates a strong selective advantage in defense. This trait, observed from to mammals, enhances immune efficiency and resolution, outweighing energetic costs in natural settings.

Potential Risks

While fever serves an adaptive role in enhancing immune responses, it imposes significant metabolic demands on the body. Each 1°C rise in core temperature elevates the metabolic rate by approximately 10–12.5%, necessitating increased energy expenditure to sustain through mechanisms such as non-shivering heat production in and . This heightened metabolic state often leads to , where the body breaks down muscle and other tissues for fuel, resulting in negative nitrogen balance due to accelerated and reduced dietary intake during illness. Fever also exerts stress on vital organs by altering cardiovascular and renal dynamics. To meet the elevated oxygen and nutrient demands, rises through increased and contractility, which can strain the myocardium, particularly in patients with preexisting cardiac conditions, leading to reduced left ventricular performance. Concurrently, renal decreases as activates the renin-angiotensin system, redirecting blood flow away from the kidneys and potentially causing hypoperfusion and impaired glomerular . At higher temperatures exceeding 40°C, fever transitions into hyperpyrexia, where physiological thresholds are breached, amplifying risks. function becomes impaired as proteins denature and cell membranes destabilize, while intensifies, generating that damage cellular components. Clinical observations underscore these drawbacks, particularly in critical care settings. Prolonged fever lasting more than 5 days correlates with worse outcomes in patients, including higher mortality rates, as sustained exacerbates and .

Treatment Strategies

Non-Pharmacological Measures

Non-pharmacological measures for fever management emphasize supportive care to alleviate discomfort, prevent complications like , and promote recovery without relying on medications. These interventions focus on maintaining , facilitating heat , optimizing the , and vigilant to ensure timely escalation if needed. is crucial during fever, as elevated body temperature increases insensible fluid losses through and , potentially leading to . Increasing fluid intake is recommended to compensate for these losses, primarily through oral rehydration with , solutions, or clear fluids; intravenous fluids may be necessary in cases of severe or inability to take oral intake. For adults, general guidelines suggest consuming at least 2-3 L of fluids per day during febrile illness, with adjustments for factors such as age, weight, and severity. Adequate helps maintain balance and supports overall physiological function during the febrile response. Physical cooling methods aim to enhance heat loss through conduction, , and while avoiding techniques that could trigger counterproductive physiological responses. Tepid sponging with lukewarm (around 32–35°C) applied to the skin, combined with light clothing and the use of fans to promote air circulation, can effectively lower body temperature and improve comfort. packs or cold should be avoided, as they may cause peripheral and , which increase metabolic heat production and potentially elevate core temperature further. Environmental adjustments and play key roles in reducing the body's thermal load and metabolic demands during fever. Maintaining between 20–25°C, removing excess , and ensuring good help prevent overheating without causing discomfort from excessive . Encouraging minimizes physical activity, which lowers oxygen consumption and overall energy expenditure, as fever itself elevates metabolic rate by about 10–12% per degree rise. Monitoring fever at home involves regular checks and adherence to guidelines for seeking medical attention, particularly in vulnerable groups. Parents and caregivers should track symptoms and escalate care for infants under 3 months with a of 38°C or higher, as this may indicate serious ; other red flags include persistent high fever (>39°C for >48 hours), , or signs. These measures empower safe home management while ensuring prompt professional intervention when warranted.

Antipyretic Medications

Antipyretic medications are pharmacological interventions designed to lower elevated body during fever by interfering with the hypothalamic set point, primarily through inhibition of (PGE2) synthesis. These agents, including acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs), provide symptomatic relief by reducing fever-associated discomfort, though they do not address the underlying cause of the fever. Clinical guidelines emphasize using antipyretics to alleviate distress rather than targeting temperature reduction alone, as fever itself is often a beneficial . Acetaminophen (also known as ) is a widely used that acts centrally as a (COX) inhibitor to block PGE2 production. In children, the recommended dose is 10–15 mg/kg orally every 4–6 hours as needed, with a maximum daily limit of 75 mg/kg to avoid hepatotoxicity; for adults, the typical dose is 500–1000 mg every 4–6 hours, not exceeding 4 g/day. Liver toxicity risk increases significantly with doses above 4 g/day in adults or excessive use in children, potentially leading to , particularly in those with preexisting liver conditions or concurrent use. Ibuprofen and other NSAIDs exert effects by inhibiting enzymes peripherally and centrally, reducing PGE2-mediated fever while also providing benefits. For pediatric patients, ibuprofen is dosed at 5–10 mg/kg every 6–8 hours, with a maximum of 40 mg/kg/day; adult doses range from 200–400 mg every 4–6 hours, up to 3200 mg/day. Caution is advised due to risks of gastrointestinal irritation, ulceration, and , as well as renal impairment, especially in dehydrated individuals or those with preexisting . Aspirin (acetylsalicylic acid), another NSAID, is effective for fever reduction in adults through similar inhibition but is generally avoided in children and adolescents due to the risk of Reye's syndrome, a rare but serious condition associated with viral infections and aspirin use. In adults, it may be used at 325–650 mg every 4–6 hours for short-term fever management, though NSAIDs like ibuprofen are often preferred to minimize gastrointestinal risks. Guidelines from health authorities strongly recommend against aspirin in pediatric populations with fever from viral illnesses. Evidence on combination or alternating antipyretic therapy, such as acetaminophen with ibuprofen, is mixed; while some studies indicate enhanced temperature reduction compared to monotherapy, major guidelines discourage routine use due to insufficient evidence of improved outcomes and potential for dosing errors leading to toxicity.

Epidemiology and Public Health

Global Prevalence

Fever represents one of the most frequent symptoms prompting healthcare-seeking behavior globally, accounting for approximately 20-30% of pediatric primary care encounters and a significant portion of adult visits in outpatient settings. In resource-limited primary healthcare centers, particularly in surveillance studies from endemic areas, fever accounts for up to 11-35% of total outpatient consultations, underscoring its role as a leading complaint across diverse populations. In tropical and subtropical regions, the incidence escalates dramatically due to vector-borne diseases, with alone responsible for an estimated 263 million cases worldwide in 2023, predominantly in and . This contrasts with lower baseline rates in temperate zones, where non-infectious causes predominate, but highlights fever's outsized burden in endemic areas where it drives repeated healthcare interactions. Mortality directly attributable to fever remains low in high-income countries, typically under 1% for uncomplicated cases, owing to timely access to diagnostics and supportive care. Globally, however, fever-associated conditions like contribute substantially to the burden, with an estimated 21.4 million sepsis-related deaths in 2021 (as of 2025 estimates), representing 31.5% of all global deaths. Post-2020 trends indicate a rebound in incidence following the relaxation of non-pharmaceutical interventions, with surges in respiratory pathogens like and reported in 44 countries experiencing at least a 10-fold increase in certain infectious diseases since 2022. Seasonal patterns persist, with peaks in winter months across the linked to increased transmission of respiratory viruses. Emerging pathogens have further amplified this rise, straining healthcare systems in both developed and developing regions. Significant disparities exist in fever prevalence and outcomes, particularly in low- and middle-income countries (LMICs), where limited diagnostic infrastructure leads to higher rates of undifferentiated febrile illnesses and delayed interventions. In these settings, fever often goes undiagnosed or mismanaged, contributing to elevated morbidity compared to high-income contexts with advanced testing capabilities. Certain at-risk groups, such as children under five and immunocompromised individuals, face amplified vulnerability, as explored in dedicated sections on demographics.

At-Risk Populations

Children represent a primary at-risk population for fever, as it constitutes a leading cause of pediatric healthcare visits, accounting for up to 30% of consultations in and emergency settings. This high frequency stems from their developing immune systems, which respond robustly to infections but can lead to complications such as febrile seizures, affecting up to 5% of children aged 6 months to 5 years. These seizures, typically benign and self-limiting, occur in the context of rapid temperature elevation and underscore the need for vigilant monitoring in young children during febrile episodes. In elderly individuals, fever often presents with a blunted physiological response, where maximum temperatures may not reach typical thresholds due to age-related , resulting in fever being absent in over 50% of infection cases among residents. Despite this attenuated fever, underlying comorbidities such as or significantly elevate mortality risks during infectious episodes, with studies indicating higher overall morbidity and death rates compared to younger adults. Immunocompromised patients, including those with or undergoing , face heightened susceptibility to fever from opportunistic infections due to impaired host defenses. In HIV-infected individuals, advanced disease stages predispose to pathogens like or , manifesting as persistent fevers that signal life-threatening dissemination. Similarly, chemotherapy-induced in cancer patients increases vulnerability to bacterial and fungal infections, where fever often serves as the initial indicator of in up to 29% of febrile episodes yielding positive microbiologic results. Travelers returning from endemic regions constitute another vulnerable group, with approximately 3% developing fever from imported infections such as or dengue, particularly after visits to tropical areas. This prevalence highlights the risk of exotic pathogens in non-immune individuals, where delayed can exacerbate outcomes due to unfamiliarity with regional disease patterns.

Historical Perspectives

Early Concepts

In ancient Greek medicine, fever was conceptualized as a manifestation of humoral imbalance within the body, a theory primarily attributed to around 400 BCE. According to this framework, health depended on the equilibrium of four humors—, , yellow , and black bile—each associated with specific qualities of hot, cold, wet, or dry. Fever was seen as arising from an excess or deficiency of these humors, leading to disturbances in the body's natural heat; for instance, "hot fevers" were linked to an overabundance of hot humors like or yellow , while "cold fevers" resulted from cold humors such as dominating. Hippocratic texts emphasized treating fevers by restoring balance through diet, purgatives, or to counteract the offending humor's qualities. This humoral approach was further systematized by the physician in the CE, who expanded on Hippocratic ideas by integrating them with Aristotelian elements and emphasizing the role of innate in fever production. described fevers as pathological elevations of the body's vital due to or corruption of the humors, classifying them into categories like continuous, intermittent, or based on their patterns and humoral origins. He maintained that hot fevers stemmed from bilious or excesses causing , whereas cold fevers involved phlegmatic stagnation, and treatments aimed to evacuate peccant humors to normalize . 's writings dominated medical thought for centuries, influencing how fevers were diagnosed and managed across the ancient and medieval worlds. During the medieval period, understandings of fever blended humoral theory with miasma concepts and religious interpretations, viewing it as either a natural imbalance or a form of divine retribution. The miasma theory, rooted in ancient ideas but prevalent in Europe from the 5th to 18th centuries, posited that fevers arose from inhaling corrupted, foul air emanating from decaying matter, which disturbed humoral equilibrium and generated internal heat. Concurrently, many medieval scholars and clergy interpreted epidemic fevers, such as those during the Black Death, as punishments from God for human sins, integrating humoral treatments with prayers and penance to appease divine wrath. This dual perspective persisted in Islamic and European medicine, where physicians like Avicenna adapted Galenic humors to explain feverish plagues while advising avoidance of miasmic environments. In the 17th and 18th centuries, early modern physicians began shifting toward more observational and classificatory approaches to fever, exemplified by Thomas Sydenham's clinical work in . Sydenham, often called the "English Hippocrates," rejected overly speculative humoral explanations in favor of detailed symptom-based descriptions, classifying fevers into types such as continued (e.g., typhus-like), intermittent (e.g., malarial), and eruptive (e.g., ), based on their courses and seasonal patterns observed in patients. Around the same time, physician Sanctorius Sanctorius pioneered quantitative measurement of fever in the 1610s by inventing early thermoscopes—sealed glass devices filled with alcohol that expanded with heat—to track bodily variations as indicators of insensible and humoral flux. These innovations laid groundwork for empirical fever assessment, though still framed within lingering humoral paradigms. Fever also permeated pre-modern , often symbolized as "hot blood" surging uncontrollably, a notion echoing humoral ideas of excess and integrated into cultural narratives across . In folk traditions, feverish states were attributed to overheated blood from passion, exertion, or causes, treated with cooling herbs, , or rituals to "let out the heat," reflecting a blend of and popular beliefs. This cultural motif underscored fever's perceived threat to vital balance, influencing community responses to outbreaks alongside formal medicine.

Key Scientific Advances

In the , significant advances in fever research were marked by the systematic study of body variations and the establishment of microbial causation for infectious diseases. Carl August Wunderlich, a , published Das Verhalten der Eigenwärme in Krankheiten in , analyzing over one million measurements from 25,000 patients to define normal as ranging from 36.2°C to 37.5°C (97.2°F to 99.5°F) and identifying fever as any elevation above 38°C (100.4°F). Wunderlich's work introduced curves as a diagnostic tool, illustrating fever patterns in diseases like typhoid and , which revolutionized clinical thermometry and shifted fever assessment from subjective sensations to objective measurements. Concurrently, Robert Koch's postulates, formulated in 1884, provided criteria to link specific microbes to diseases, many of which manifest with fever, such as and , thereby establishing the germ theory's role in understanding fever as a symptom of bacterial infection. The 20th century brought deeper insights into fever's molecular mechanisms, beginning with the identification of endogenous pyrogens—host-derived substances that mediate fever in response to infection. In 1948, Paul B. Beeson demonstrated that leukocytes produce a fever-inducing factor, termed endogenous pyrogen, in response to bacterial toxins, distinguishing it from direct microbial effects and laying the groundwork for cytokine research. By the 1970s, Anthony S. Milton and colleagues elucidated the role of (PGE2) as a key mediator, showing that PGE2 synthesis in the elevates the thermoregulatory set point when injected intracerebrally in cats and rabbits, confirming its central action in pyrexia. The advanced this further with the identification of cytokines as the primary endogenous pyrogens; Charles A. Dinarello cloned interleukin-1 (IL-1) in 1984, proving it identical to leukocytic pyrogen and responsible for inducing fever through PGE2 production via pathways. Into the 21st century, genomic approaches have illuminated the genetic underpinnings of fever responses, revealing how variants influence inflammatory cascades. Studies of , such as , identified mutations in the encoding pyrin, which regulates IL-1β production, providing insights into innate immune pathways that drive fever during infections. The in the 2020s offered critical observations on hyperinflammation, where severe cases exhibited cytokine storms—marked elevations in IL-6, IL-1, and TNF-α—leading to persistent high fevers and multiorgan dysfunction, prompting targeted therapies like IL-6 inhibitors (e.g., ) to mitigate fever-associated complications. Therapeutically, the witnessed a pivotal shift from invasive practices like , rooted in humoral theory, to pharmacological s, exemplified by the commercialization of aspirin (acetylsalicylic acid) in 1899 by , which inhibited synthesis to safely reduce fever and without the risks of earlier methods. This transition underscored fever's treatability as a symptom rather than a entity, paving the way for modern evidence-based antipyretic use.

Sociocultural Dimensions

Cultural Perceptions

In various mythological traditions, fever has been interpreted as a manifestation of demonic possession or affliction. For instance, in ancient theological and beliefs, the intense of fever was often attributed to invading the body, necessitating rituals of to restore balance. In , illnesses such as fever are frequently viewed as induced by ancestral spirits, , or evil entities, reflecting a broader cultural framework where physical symptoms signal spiritual disequilibrium. Similarly, some historical European and Mesopotamian myths linked fever to demons like , a associated with and requiring protective amulets or invocations for expulsion. Conversely, certain cultural narratives portray fever as a purifying force akin to fire, symbolizing renewal or the expulsion of impurities. In Paracelsian traditions of , fever was regarded as a vital cleansing mechanism orchestrated by the body's to purge toxins, aligning with alchemical views of fire as transformative. Indigenous practices, such as Native American sweat lodge ceremonies, intentionally induce fever-like states through heated rituals to facilitate spiritual purification and healing, echoing shamanic beliefs where elevated body temperature serves as a for visionary experiences and communal restoration. Contemporary cultural perceptions of fever reveal stark contrasts between and traditional systems. In societies, high fever is often stigmatized as a dangerous symptom requiring immediate suppression to prevent complications like seizures, fostering widespread parental anxiety and reliance on antipyretics. In contrast, Ayurvedic medicine conceptualizes jvara (fever) as a "hot" imbalance of doshas—particularly —manifesting as and digestive fire disruption, where moderate fever is tolerated as the body's natural response to restore equilibrium rather than an enemy to be aggressively combated. Alternative practices for managing fever emphasize herbal and spiritual approaches rooted in cultural wisdom. Willow bark, containing , has been employed for millennia in European and Chinese traditions as an to alleviate fever and pain, serving as the historical precursor to modern aspirin. Spiritual healing, prevalent in shamanic and African contexts, involves rituals like chants, egg cleansing, or invocations to appease spirits believed to cause fever, integrating community support to address both physical and metaphysical dimensions of illness. The COVID-19 pandemic further shaped perceptions, amplifying fever-related anxieties globally as a key symptom, leading to increased home monitoring and, in some traditional contexts, blended approaches with biomedical advice. In literature and film, fever frequently symbolizes human vulnerability and existential fragility. Edith Wharton's novella Roman Fever uses malaria (termed "Roman fever") as a metaphor for hidden dangers and emotional exposure in high society, underscoring themes of suppressed desire and peril. Similarly, depictions of scarlet fever in 19th-century novels like Louisa May Alcott's Little Women evoke societal fears of contagion and mortality, portraying fever as a narrative device to heighten character isolation and resilience amid crisis. In modern cinema, such as Maya Da-Rin's The Fever, fever represents cultural dislocation and bodily betrayal for an Indigenous protagonist navigating urbanization, amplifying motifs of alienation and survival.

Pediatric Fever Management

Pediatric fever management emphasizes assessing the child's overall well-being and comfort rather than solely targeting temperature reduction, as fever itself is often a beneficial unless causing distress. The (AAP) recommends evaluating infants and children for signs of serious illness, such as , poor feeding, or , and using antipyretics primarily to alleviate discomfort from fever-associated symptoms like or . For well-appearing children beyond the neonatal period, routine laboratory testing or is not indicated if no focal is suspected, shifting focus to supportive care. Acetaminophen is considered safe for infants from birth under medical guidance, while ibuprofen is approved for use starting at 6 months of age to manage fever and , with dosing based on weight (typically 10-15 mg/kg every 4-6 hours for acetaminophen and 5-10 mg/kg every 6-8 hours for ibuprofen). A significant in pediatric fever is parental "fever ," where misconceptions lead to excessive concern and interventions; surveys indicate that approximately % of parents experience heightened anxiety about fever, often believing it causes or other harms even at mild elevations below 38°C. To address this, clinicians prioritize education, reassuring parents that fevers up to 40°C are generally harmless in healthy children and advising monitoring for behavioral changes rather than obsessing over readings. This approach reduces unnecessary medical visits and promotes home-based care, such as encouraging fluids, light clothing, and rest to maintain and comfort. Children with fever warrant consideration of common age-specific etiologies that may require targeted evaluation, including viral infections like (human herpesvirus 6), which presents with high fevers (often 39-40°C) lasting 3-5 days followed by a and carries a 10-15% risk of febrile seizures in affected toddlers. Bacterial causes such as acute are prevalent in young children, accounting for around 20% of visits in children under 6 years, and may necessitate antibiotics if accompanied by ear pain or effusion. Vaccinations have substantially mitigated risks of severe bacterial fevers; conjugate vaccines against type b (Hib) and have reduced invasive infections like bacteremia and by over 90% in vaccinated populations, decreasing the overall burden of high-risk fevers. Globally, pediatric fever management varies, with developing regions showing higher reliance on due to limited access to formal healthcare; for example, 22% of caregivers in (sub-Saharan Africa) use herbal remedies or home practices as first-line treatment for childhood fevers, often delaying biomedical interventions, while similar patterns are observed in . In these contexts, integration efforts educate traditional practitioners on recognizing danger signs like prolonged fever or seizures to bridge gaps in care.

Comparative Aspects

Fever in Non-Human Animals

Fever responses are conserved across vertebrates through shared pyrogen pathways, where cytokines such as interleukin-1 (IL-1) act as endogenous pyrogens to elevate the hypothalamic temperature set point, a mechanism observed from fish to mammals. The IL-1 receptor family is present in all vertebrates, originating from ancestral gene duplications, enabling similar inflammatory signaling that triggers fever during infection. This conservation underscores fever's ancient role in innate immunity, with pyrogens like IL-1β and tumor necrosis factor-α produced in response to pathogens across species. In reptiles, which are ectothermic, true physiological fever is limited, but they exhibit behavioral to achieve set point elevation by seeking warmer microhabitats, such as basking under heat sources during . This behavioral fever allows reptiles to raise their body temperature by 2–5°C above preferred levels, enhancing immune function without internal heat generation. For instance, infected preferentially select higher temperatures in experimental gradients, mimicking the elevated set point seen in endotherms. Among endothermic vertebrates, mammals display fever mechanisms closely analogous to those in humans, involving to generate and reach the raised set point, as observed in during where rapid muscle contractions increase core temperature. Cats, similarly, employ panting as a primary evaporative cooling mechanism once the set point is achieved, preventing while maintaining the febrile state, particularly in response to viral pathogens. In contrast, utilize wing-spreading to facilitate heat dissipation through increased surface area and gular fluttering, aiding in during fever when ambient conditions or metabolic might exceed the elevated set point. Specific examples illustrate these responses in veterinary contexts; , caused by orthomyxoviruses, induces acute fever with core temperatures rising to 40–42°C, accompanied by coughing and nasal discharge, highlighting the disease's respiratory impact. In bovine , with often presents with undulant fever exceeding 40°C, alongside reproductive complications like abortion, serving as a key diagnostic indicator in herds. Veterinary thresholds for fever in are typically set above 39.5°C, as normal rectal temperatures range from 38.0–39.0°C, with elevations signaling or . Poikilotherms, including many and amphibians, lack the physiological capacity for true fever due to their variable body temperatures but demonstrate "behavioral fever" by actively moving to warmer environments upon exposure, thereby increasing immune . This strategy, seen in species like during viral challenge, elevates preferred temperatures by several degrees without altering internal set points, distinguishing it from endothermic mechanisms.

Evolutionary Insights

Fever represents an ancient physiological response conserved across vertebrates, emerging over 600 million years ago in the common ancestor of warm- and species, where it is tightly linked to the activation of innate immune mechanisms such as signaling and function. This trait likely originated with the evolution of sophisticated innate immunity in early vertebrates, predating the divergence of vertebrates around 420 million years ago, as evidenced by behavioral fever in ectothermic and reptiles that enhances clearance without endogenous . The persistence of fever through evolutionary time underscores its integration into core immune defenses, with molecular pathways involving prostaglandins and heat shock proteins showing across distant taxa. Selective pressures favoring fever primarily stem from its role in combating parasitic and bacterial infections, where modest temperature elevations confer a clear survival advantage by impairing pathogen replication while bolstering host defenses. For instance, in malaria caused by Plasmodium falciparum, exposure to febrile temperatures around 40°C drastically reduces the parasite's erythrocytic multiplication rate from approximately 9-fold at 37°C to less than 0.5-fold, effectively halting proliferation and aiding clearance. Similar benefits are observed in ectotherms; desert lizards infected with bacteria exhibit 75% mortality if prevented from raising their body temperature by 2°C, compared to near-complete survival when allowed to fever, highlighting fever's adaptive value against extracellular pathogens under natural selection. These pressures likely drove the conservation of fever, as pathogens sensitive to thermal stress—prevalent in ancestral environments—would have rewarded hosts capable of mounting this response. However, fever's evolutionary retention also reflects a balance of trade-offs, particularly its substantial metabolic cost, which limits its intensity to mild elevations that maximize net benefits. Raising core temperature by 1°C in endotherms demands a 10–12.5% increase in metabolic rate, equivalent to the energy expenditure of sustained , explaining why fevers rarely exceed 40–41°C despite greater efficacy at higher temperatures. Studies in mice infected with pathogens demonstrate an optimal fever set point around 39°C, where immune enhancement peaks while avoiding excessive energy drain or risks like protein denaturation; beyond this, survival declines due to heightened physiological stress. This moderation suggests selection for regulated , prioritizing long-term host viability over aggressive responses. In , genetic variations in thermoregulatory and immune genes have modulated fever responses, often tied to migrations from tropical origins to diverse climates over the past 100,000 years. Populations of recent tropical ancestry, such as Tsimane Amazonians, maintain lower basal body temperatures (averaging 36.5–37°C) compared to temperate-zone groups, potentially resulting in attenuated fever peaks during —a pattern linked to ancestral adaptations to warmer, pathogen-rich environments where excessive heating was less advantageous. Conversely, variants in genes like those regulating synthesis show higher frequencies in Eurasian populations, possibly selected for enhanced fever in cooler climates to counter cold-stressed infections, illustrating how post-migratory selective forces fine-tuned this ancient trait.